Liquid biopsy in lung cancer

Area of Science:

• Oncology
• Molecular Diagnostics
• Cancer Research

Background:

• Lung cancer is a leading cause of cancer mortality globally.
• Current diagnostic methods like tissue biopsy are invasive and may not capture tumor heterogeneity.
• Lack of standardized approaches for early detection and monitoring hinders effective lung cancer management.

Purpose of the Study:

• To critically examine the role and clinical implications of liquid biopsy in lung cancer.
• To highlight liquid biopsy as a promising non-invasive diagnostic and monitoring tool.
• To discuss the potential of liquid biopsy in improving lung cancer diagnosis, treatment, and prognosis.

Main Methods:

• Review of current literature on liquid biopsy techniques in lung cancer.
• Analysis of components of liquid biopsy, including circulating tumor cells, cell-free DNA, and extracellular vesicles.
• Evaluation of the diagnostic and prognostic capabilities of liquid biopsy compared to conventional methods.

Main Results:

• Liquid biopsy provides a non-invasive method for detecting and monitoring lung cancer.
• It allows for repeated analysis, facilitating real-time tracking of tumor recurrence, metastasis, and treatment response.
• Advancements in molecular technology are enhancing the efficacy and potential of liquid biopsy.

Conclusions:

• Liquid biopsy represents a significant advancement in lung cancer diagnostics and management.
• Its non-invasive nature and real-time monitoring capabilities offer substantial clinical advantages.
• Liquid biopsy holds great promise for improving patient outcomes in lung cancer care.